Share

University Hospital Bristol has presented groundbreaking results at the British Radiation Safety Society (BRSS) conference, showcasing the use of TrueInvivo’s® DOSEmapper™ technology in gamma knife radiosurgery. The innovative micro silica bead TLD system provided precise dose measurements, ensuring accurate delivery and improved patient safety in stereotactic radiosurgery.
This marks a significant advancement in dosimetry, highlighting the potential of DOSEmapper™ to enhance radiation safety and accuracy in complex treatments.
Related Posts
Revolutionary DOSEmapper™ reader produces glow curve graph, offering rapid measurement compared to traditional TLD readers.
Mount Vernon Cancer Centre pioneers first internal invivo dosimetry with TRUEnvivo® DOSEmapper™, revolutionising radiotherapy precision, patient safety, and treatment accuracy.
TRUEinvivo joined SyndicateRoom investment platform in February 2019, leveraging its network to connect with potential investors, alongside Nexus Investment Ventures Ltd,
Dr. Shakardokht Jafari named 2024 Innovator of the Year at Dynamic Awards in Brighton's Grand Hotel.

